Nalaganje...

Combination of Whole-Brain Radiotherapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Improves Overall Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Brain metastases (BM) cause morbidity and mortality in patients with non-small cell lung cancer (NSCLC). The use of upfront epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and withholding of whole-brain radiation therapy (WBRT) is controversial. We aim to investigate the im...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Chen, Chien-Hung, Lee, Hsin-Hua, Chuang, Hung-Yi, Hung, Jen-Yu, Huang, Ming-Yii, Chong, Inn-Wen
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721307/
https://ncbi.nlm.nih.gov/pubmed/31370314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081092
Oznake: Označite
Brez oznak, prvi označite!